MediBloc (MED), as a blockchain-based open information service platform for medical data management, has been making significant strides since its inception in 2017. As of 2025, MediBloc's market capitalization has reached $32,102,430, with a circulating supply of approximately 10,644,041,819 tokens, and a price hovering around $0.003016. This asset, often referred to as the "medical data blockchain," is playing an increasingly crucial role in revolutionizing healthcare information management.
This article will provide a comprehensive analysis of MediBloc's price trends from 2025 to 2030, combining historical patterns, market supply and demand, ecosystem development, and macroeconomic factors to offer professional price predictions and practical investment strategies for investors.
MED is currently trading at $0.003016, down 0.72% in the last 24 hours. The token has seen significant price depreciation over the past year, dropping 67.56% from its value a year ago. Short-term price action shows a 12.26% decrease over the past week and a 22.09% decline over the last month. MED's market capitalization stands at $32,102,430, ranking it 748th among all cryptocurrencies. The current price represents a 99.14% decrease from its all-time high, indicating a prolonged bearish trend.
Click to view current MED market price

2025-11-18 Fear and Greed Index: 11 (Extreme Fear)
Click to view the current Fear & Greed Index
The crypto market is gripped by extreme fear, with the sentiment index plummeting to 11. This level of pessimism often signals a potential buying opportunity for contrarian investors. However, it's crucial to approach with caution and conduct thorough research. Remember, market cycles are inevitable, and this extreme fear could precede a trend reversal. Stay informed, manage risks wisely, and consider dollar-cost averaging if you decide to enter the market during this fearful phase.

The address holdings distribution data for MED shows an empty table, indicating a lack of available information on top holders. This absence of data makes it challenging to conduct a comprehensive analysis of MED's concentration characteristics and market structure.
Without specific holder information, it's not possible to determine if there's an excessive concentration of tokens or assess the potential impact on price volatility and market manipulation. The lack of visible large holders could suggest a more distributed ownership structure, but this cannot be confirmed without further data.
Given the limited information, it's crucial to approach any conclusions about MED's market characteristics, such as decentralization or on-chain stability, with caution. Additional research and data collection would be necessary to provide a meaningful analysis of MED's token distribution and its implications for the market.
Click to view the current MED Holdings Distribution

| Top | Address | Holding Qty | Holding (%) |
|---|
| 年份 | 预测最高价 | 预测平均价格 | 预测最低价 | 涨跌幅 |
|---|---|---|---|---|
| 2025 | 0.00337 | 0.00301 | 0.0024 | 0 |
| 2026 | 0.00398 | 0.00319 | 0.00274 | 6 |
| 2027 | 0.00505 | 0.00358 | 0.00194 | 19 |
| 2028 | 0.00479 | 0.00432 | 0.00259 | 43 |
| 2029 | 0.00497 | 0.00456 | 0.00355 | 51 |
| 2030 | 0.00509 | 0.00476 | 0.00314 | 58 |
(1) Long-term Holding Strategy
(2) Active Trading Strategy
(1) Asset Allocation Principles
(2) Risk Hedging Solutions
(3) Secure Storage Solutions
MED presents a high-risk, high-potential investment in the blockchain-based healthcare information sector. While it offers innovative solutions for medical data management, investors should be aware of the significant volatility and regulatory uncertainties in the cryptocurrency market.
✅ Beginners: Consider small, exploratory investments to understand the market dynamics ✅ Experienced investors: Implement a dollar-cost averaging strategy with strict risk management ✅ Institutional investors: Conduct thorough due diligence and consider MED as part of a diversified crypto portfolio
Cryptocurrency investments carry extremely high risks, and this article does not constitute investment advice. Investors should make decisions based on their own risk tolerance and are advised to consult professional financial advisors. Never invest more than you can afford to lose.
Based on current analyst ratings, MED stock is not considered a buy. It has no Buy ratings and mostly Hold recommendations. However, the market can change rapidly.
Medifast stock (MED) is predicted to reach an average price of $100.25 in 2025, with a potential high of $200.45 and a low of $0.0472.
Maxeon stock is projected to reach $13.42 by 2030, $8.62 by 2040, and $81.88 by 2050, based on current market trends.
Yes, Medtronic is a solid long-term buy. It offers steady growth, strong financials, and consistent dividends. Recent trends and attractive valuation support its investment potential.
Share
Content